Exagen Inc. Common Stock
$4.683
USD
Last updated on --.
24h volume41.26K
24h highest4.6850 USD
24h lowest4.4600 USD
24h Price movement+4.53%
XGN recent prices
24 Hours
+4.53%+$0.203
30 days
+29.11%+$1.010
60 days
+50.84%+$1.510
90 days
+36.48%+$1.120
Key data
Previous close4.4800 USD
Market cap103.65M USD
Volume41.26K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.83000 USD
Net income (FY)-20.17M USD
Revenue (FY)68.38M USD
Last report dateMay 11, 2026
About Exagen Inc. Common Stock
HeadquartersVISTA
Employees (FY)220.00
Revenue per employee (FY)310.83K USD
Net income per employee (FY)-91.66K USD
Listed onNasdaq
XGN conversion tables
 |  |
|---|---|
| 0.5 XGN | 2.341 USD |
| 1 XGN | 4.683 USD |
| 5 XGN | 23.41 USD |
| 10 XGN | 46.83 USD |
| |
|---|---|
| 0.5 USD | 0.10677 XGN |
| 1 USD | 0.21354 XGN |
| 5 USD | 1.067 XGN |
| 10 USD | 2.135 XGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XGN is trading at $4.683, +4.53% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XGN is currently trading at $4.683, +4.53% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-MEDICAL LABORATORIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XGN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XGN's historical range and other companies in the SERVICES-MEDICAL LABORATORIES sector.
Exagen Inc. Common Stock's market cap is currently 103.65M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume41.26K
24h highest4.6850 USD
24h lowest4.4600 USD
24h Price movement+4.53%
Start trade with XGN Perpetual
Sign up to trade